Busse WW, Bleecker ER, FitzGerald JM, Ferguson GT, et al. Benralizumab for Adolescent Patients with Severe, Eosinophilic Asthma: Safety and Efficacy after Three Years of Treatment. J Allergy Clin Immunol 2021 Feb 17. pii: S0091-6749(21)00226.
PMID: 33609624